UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo
|
2019-02-07 14:40
라인
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi
|
2019-02-07 14:40
라인
Korean firms ink $232 million surgical device export deals in Dubai
Korean medical device makers showcased an integrated showroom of surgical d...
by Park Gi-taek
|
2019-02-07 11:55
라인
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo
|
2019-02-07 11:09
라인
EM physician from Korea enjoys work-life balance in America
She had a solid reason to live as a doctor in the United States: She wanted...
by Song Soo-youn
|
2019-02-06 06:00
라인
[Special] Why did these med students become YouTubers?
People today are living in an era of YouTube. It exerts enormous influence ...
by Cho In-sung
|
2019-02-05 07:27
라인
[Special] Nearly one-third of children under 5 suffer from chronic malnutrition
It is lunchtime and children rushed seemingly from nowhere. The cafeteria t...
by Yoon Won-sub
|
2019-02-04 06:00
라인
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo
|
2019-02-01 17:04
라인
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi
|
2019-02-01 17:02
라인
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi
|
2019-02-01 15:38
라인
Medytox, Daewoong continue to squabble over BTX
A heated debate is continuing between Medytox and Daewoong Pharmaceuticals ...
by Lee Han-soo
|
2019-02-01 15:36
라인
Samsung BioLogics posts ₩535.8 billion in 2018 sales
Samsung BioLogics said Thursday that it recorded 535.8 billion won ($479 mi...
by Lee Han-soo
|
2019-02-01 11:56
라인
Santen Pharma to sell Huonland’s eye drop in China
Huonland said Wednesday that it has signed a memorandum of understanding wi...
by Lee Han-soo
|
2019-02-01 11:56
라인
14 pharmaceuticals to release gastritis generic drugs soon
Fourteen pharmaceutical firms are to roll out generic copies of Stillen 2X ...
by Lee Hye-seon
|
2019-02-01 11:55
라인
Boryung Bio, CancerRop launch Wilson's disease screening test
Boryung Biopharma said that it plans to launch Wilson's disease screeni...
by Lee Han-soo
|
2019-02-01 10:59
라인
AbClon transfers target antibody technology to GC Labcell
GC Labcell said Wednesday that it has signed a 3 billion won ($2.7 million)...
by Lee Han-soo
|
2019-01-31 16:23
라인
[Special] Siem Reap Provincial Hospital struggles with poor facilities
Tuk Tuk, a three-wheeled taxi, stands in front of the emergency room at Sie...
by Yoon Won-sub
|
2019-01-31 15:32
라인
Novo Nordisk’s growth hormone injection gets expanded coverage
Novo Nordisk said Wednesday that the Ministry of Health and Welfare would e...
by Lee Han-soo
|
2019-01-31 15:18
라인
‘Pseudoephedrine-containing drugs could cause acute skin reaction’
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon
|
2019-01-31 14:34
라인
Kwangdong dismisses rumors of terminating sales for Contrav
Kwangdong Pharmaceutical denied Thursday rumors of the company stopping sal...
by Lee Han-soo
|
2019-01-31 14:32
-
이전
151
152
153
154
155
156
157
158
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top